According to the preliminary 2014 data, the Penta Investments Group reported sales of Dr. Max pharmacies in the Czech Republic, Poland and Slovakia at EUR 930m. EBITDA amounted to EUR 55m. The group operates about 900 pharmacies in the Czech Republic, Slovakia and Poland, External Relations Manager of Penta Investments Martin Danko confirmed to ČIANEWS. In 2015, the group plans to invest in the hospital segment in the Czech Republic.
Source: www.cianews.cz
